Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7996247 | 0.84 | CA1 (0.42) | MAPTCA1CA2CA4CA7 | |
| SCHEMBL5845482 | 0.83 | CA1 (0.56) | MAPTHPGDCA1CA2CA4 | |
| SCHEMBL5846939 | 0.83 | CA1 (0.56) | MAPTHPGDCA1CA2CA4 | |
| SCHEMBL5845479 | 0.83 | CA1 (0.56) | MAPTHPGDCA1CA2CA4 | |
| SCHEMBL21827872 | 0.80 | ALDH1A1 (0.41) | MAPTHPGDCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21827873 | 0.80 | ALDH1A1 (0.41) | MAPTHPGDCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL6954090 | 0.79 | MAPT (0.51) | MAPTHPGDCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL6954084 | 0.79 | MAPT (0.51) | MAPTHPGDCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL14635871 | 0.77 | CA1 (0.42) | MAPTCA1CA2CA4CA7 | |
| SCHEMBL6787127 | 0.75 | CYP3A4 (0.42) | MAPTHPGDCYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001068642-A1 | DIHYDROPYRIMIDINES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001068639-A1 | DIHYDROPYRIMIDINE-5-CARBOXYLIC ACID ESTERS AND USE THEREOF AS MEDICAMENTS AGAINST VIRAL DISEASES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-20 | — | — | WO | disclosed |